FTC approves Medtronic acquisition of Covidien

SHARE FTC approves Medtronic acquisition of Covidien

NEW YORK — The U.S. Federal Trade Commission said Wednesday that it approved Medtronic’s $42.9 billion acquisition of Covidien after the medical device maker agreed to sell a business that makes a type of catheter used in veins.

Medtronic said it will sell Covidien’s drug-coated balloon catheter business to Colorado Springs, Colorado-based The Spectranetics Corp. shortly after its acquisition of Covidien closes. Medtronic expects the deal to close early next year. It still needs to be cleared by regulators and authorization from Ireland, where Covidien is based. Both companies’ shareholders also need to approve the acquisition.

Medtronic first announced the deal to buy Covidien in June.

Shares of Minneapolis-based Medtronic shares rose 69 cents to close at $73.48 Wednesday. U.S.-traded shares of Covidien rose $1.22 to close at $100.54. Spectranetics shares rose 29 cents to close at $32.29.

The Latest
The 47-year-old fell from a garage in the first block of East Delaware Place Tuesday afternoon, police said.
Hanukkah, the Jewish Festival of Lights, is an eight-day commemoration that begins Thursday.
The decision follows the city of Chicago’s release of an environmental report Friday that showed the location at 38th and California required metals and chemicals cleanup.
Why isn’t Northwestern ranked after beating No. 1 Purdue? The answer must be that it would make too much sense. But that’s just one of many examples.
Robinson’s duties will include helping shape the strategic direction of the organization, working collaboratively with board, staff and the wider community and driving new systems and policies to “ensure the Center is equipped to address the evolving challenges and needs of today’s LGBTQ community.”